MoneyWorks4Me

Hikal board to consider audited financial results

13 May 2013 Evaluate

Hikal has informed that a meeting of the board of directors of the company will be held on May 16, 2013, to consider and to take on record audited financial results for the year ended March 31, 2013 & also consider recommendation of Dividend for the year ended March 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..